RVMD Archived Articles
Revolution Medicines, Inc. (RVMD): Pioneering the Treatment of RAS-Addicted Cancers
Published on March 15, 2025
Revolution Medicines (NASDAQ:RVMD) - A Pioneer in Targeted Therapies for RAS-Addicted Cancers
Published on November 02, 2024
Revolution Medicines, Inc. (RVMD): Pioneering RAS(ON) Inhibitors to Transform the Treatment of RAS-Addicted Cancers
Published on September 24, 2024